p53 Expression in circulating lymphocytes of non-melanoma skin cancer patients from an arsenic contaminated region in Mexico. A pilot study

By Salazar Ana M.   Calderón-Aranda Emma   Cebrián Mariano E.   Sordo Monserrat   Bendesky Andrés   Gómez-Muñoz Arístides   Acosta-Saavedra Leonor   Ostrosky-Wegman Patricia  

Molecular and Cellular Biochemistry, Vol. 255, Iss. 1-2, 2004-01 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite

Cetuximab in non-small cell lung cancer

By Ademuyiwa Foluso O   Hanna Nasser  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in the treatment of patients with colorectal cancer

By Garrett Christopher R   Eng Cathy  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 7, 2011-07 ,pp. : 937-949

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab: still an option in the treatment of pancreatic cancer?

By Faloppi Luca   Andrikou Kalliopi   Cascinu Stefano  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 791-801

Informa Healthcare

Access to resources Recommend Favorite

The role of cetuximab in the treatment of squamous cell cancer of the head and neck

By Burtness Barbara  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 8, 2005-08 ,pp. : 1085-1093

Informa Healthcare

Access to resources Recommend Favorite